Kolhapur researchers receives 20 years patent for their Breast Cancer drug

▴ Kolhapur researchers receives 20 years patent for their Breast Cancer drug
A new breakthrough for Breast Cancer patients

Researchers at the Shivaji University Kolhapur (SUK) have received a patent for the chemical complex (molecule) drug synthesised in a university lab which showed anti-breast cancer properties.

Assistant Professor Prakash Bansode under the guidance of Gajanan Rashinkar synthesised the drug molecule for over 3 months.

The molecule contains a Ferrocine compound which normally kills normal cells also during chemotherapy apart from destroying normal cells. To overcome the problem researchers coupled the compound with Carbene structure to which they added metallic components such as Gold, Silver and Platinum. 

According to the researchers, the drug was screened at Advanced Cancer Research Centre of Tata Memorial. The patent application which was filed in March 2018 was reviewed and the drug was granted a 20 years product patent.

Tags : #Kolhapur #ShivajiUniversityKolhapur #ShivajiUniversity #Ferrocine #BreastCancerTreatment #TataCancerMemorial #TataAdvanceResearchCentre #PrakashBansode #GajananRashinkar

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Tier-2 and Tier-3 Cities: India's Next Big Healthcare Growth StorySeptember 18, 2026
Why Regional Hospital Chains Are Becoming More Important in IndiaSeptember 18, 2026
The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026